Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Seckinger

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1990
Characterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptorP Seckinger, J H Zhang, B Hauptmann, et al.
European Journal of Immunology|May 1, 1990
Tumor necrosis factor inhibitor: purification, NH2-terminal amino acid sequence and evidence for anti-inflammatory and immunomodulatory activitiesP Seckinger, E Vey, G Turcatti, et al.
European Journal of Immunology|May 1, 1989
Interleukin 1 and tumor necrosis factor enhance transcription from the SV40 early promoter in a T cell lineG Plaetinck, M C Combe, P Corthésy, et al.
Journal of Autoimmunity|April 1, 1989
A natural interleukin 1 (IL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic isletsM D Dayer-Métroz, C B Wollheim, P Seckinger, et al.
Arthritis and Rheumatism|December 1, 1990
Modulation of the effects of interleukin-1 on glycosaminoglycan synthesis by the urine-derived interleukin-1 inhibitor, but not by interleukin-6P Seckinger, I Yaron, F A Meyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1987
A urine inhibitor of interleukin 1 activity that blocks ligand bindingP Seckinger, J W Lowenthal, K Williamson, et al.
The Journal of Clinical Investigation|October 1, 1986
Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s)J F Balavoine, B de Rochemonteix, K Williamson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1990
Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin productionP Seckinger, J Klein-Nulend, C Alander, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1987
A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alphaP Seckinger, K Williamson, J F Balavoine, et al.
The Journal of Biological Chemistry|September 5, 1991
An interleukin 1 beta point mutant demonstrates that jun/fos expression is not sufficient for fibroblast metalloproteinase expressionW Conca, P E Auron, M Aoun-Wathne, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1990
Characterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptorP Seckinger, J H Zhang, B Hauptmann, et al.
European Journal of Immunology|May 1, 1990
Tumor necrosis factor inhibitor: purification, NH2-terminal amino acid sequence and evidence for anti-inflammatory and immunomodulatory activitiesP Seckinger, E Vey, G Turcatti, et al.
European Journal of Immunology|May 1, 1989
Interleukin 1 and tumor necrosis factor enhance transcription from the SV40 early promoter in a T cell lineG Plaetinck, M C Combe, P Corthésy, et al.
Journal of Autoimmunity|April 1, 1989
A natural interleukin 1 (IL-1) inhibitor counteracts the inhibitory effect of IL-1 on insulin production in cultured rat pancreatic isletsM D Dayer-Métroz, C B Wollheim, P Seckinger, et al.
Arthritis and Rheumatism|December 1, 1990
Modulation of the effects of interleukin-1 on glycosaminoglycan synthesis by the urine-derived interleukin-1 inhibitor, but not by interleukin-6P Seckinger, I Yaron, F A Meyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1987
A urine inhibitor of interleukin 1 activity that blocks ligand bindingP Seckinger, J W Lowenthal, K Williamson, et al.
The Journal of Clinical Investigation|October 1, 1986
Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s)J F Balavoine, B de Rochemonteix, K Williamson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1990
Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin productionP Seckinger, J Klein-Nulend, C Alander, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1987
A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alphaP Seckinger, K Williamson, J F Balavoine, et al.
The Journal of Biological Chemistry|September 5, 1991
An interleukin 1 beta point mutant demonstrates that jun/fos expression is not sufficient for fibroblast metalloproteinase expressionW Conca, P E Auron, M Aoun-Wathne, et al.
Pageof 2